Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

686 ARTÍCULOS , VIENDO DEL 616 AL 630

Commentary on Comparison of Machine Learning-based Approaches to Predict the Conversion to Alzheimer's Disease from Mild Cognitive Impairment

Rossini PM, Miraglia F, Vecchio F.

Neuroscience. 2023 Mar 15;514:141-142. doi: 10.1016/j.neuroscience.2022.12.018. Epub 2022 Dec 30.

The impact of social isolation from COVID-19-related public health measures on cognitive function and mental health among older adults: A systematic review and meta-analysis

Prommas P, Lwin KS, Chen YC, Hyakutake M, Ghaznavi C, Sakamoto H, Miyata H, Nomura S.

Ageing Res Rev. 2023 Mar;85:101839. doi: 10.1016/j.arr.2022.101839. Epub 2022 Dec 31.

Commentary on "Projection of Care Partners' Preferences in the Proxy Assessments of Everyday Preferences for Persons With Cognitive Impairment"

Moorman SM.

Am J Geriatr Psychiatry. 2023 Apr;31(4):264-266. doi: 10.1016/j.jagp.2022.12.189. Epub 2022 Dec 24.

Effect of online tDCS to left somatomotor cortex on neuropsychiatric symptoms among older adults at risk for dementia

Turnbull A, Anthony M, Tadin D, Porsteinsson AP, Heffner K, Lin FV.

Cortex. 2023 Feb;159:131-141. doi: 10.1016/j.cortex.2022.10.015. Epub 2022 Dec 17.

Omega-3 fatty acids and cognitive function

Welty FK.

Curr Opin Lipidol. 2023 Feb 1;34(1):12-21. doi: 10.1097/MOL.0000000000000862. Epub 2022 Nov 25.

Diagnostic performance of the six-item cognitive impairment test as first-step screening for dementia: a meta-analysis

Park SH.

Brain Impair. 2023 Sep;24(2):412-423. doi: 10.1017/BrImp.2022.22. Epub 2022 Sep 6.

Subjective cognitive decline and stage 2 of Alzheimer disease in patients from memory centers

Jessen F, Wolfsgruber S, Kleineindam L, Spottke A, Altenstein S, Bartels C, Berger M, Brosseron F, Daamen M, Dichgans M, Dobisch L, Ewers M, Fenski F, Fliessbach K, Freiesleben SD, Glanz W, Görß D, Gürsel S, Janowitz D, Kilimann I, Kobeleva X, Lohse A, Maier F, Metzger C, Munk M, Preis L, Sanzenbacher C, Spruth E, Rauchmann B, Vukovich R, Yakupov R, Weyrauch AS, Ziegler G, Schmid M, Laske C, Perneczky R, Schneider A, Wiltfang J, Teipel S, Bürger K, Priller J, Peters O, Ramirez A, Boecker H, Heneka MT, Wagner M, Düzel E.

Alzheimers Dement. 2023 Feb;19(2):487-497. doi: 10.1002/alz.12674. Epub 2022 Apr 22.

Clinical utility of cerebrospinal fluid biomarkers in the evaluation of cognitive impairment: a systematic review and meta-analysis

Hazan J, Wing M, Liu KY, Reeves S, Howard R.

J Neurol Neurosurg Psychiatry. 2023 Feb;94(2):113-120. doi: 10.1136/jnnp-2022-329530. Epub 2022 Sep 12.

Increasing participant diversity in AD research: Plans for digital screening, blood testing, and a community-engaged approach in the Alzheimer's Disease Neuroimaging Initiative 4

Weiner MW, Veitch DP, Miller MJ, Aisen PS, Albala B, Beckett LA, Green RC, Harvey D, Jack CR Jr, Jagust W, Landau SM, Morris JC, Nosheny R, Okonkwo OC, Perrin RJ, Petersen RC, Rivera-Mindt M, Saykin AJ, Shaw LM, Toga AW, Tosun D, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2023 Jan;19(1):307-317. doi: 10.1002/alz.12797. Epub 2022 Oct 9.

Successful aging after elective surgery II: Study design and methods

Hshieh TT, Schmitt EM, Fong TG, Arnold S, Cavallari M, Dickerson BC, Dillon ST, Jones RN, Libermann TA, Marcantonio ER, Pascual-Leone A, Shafi MM, Touroutoglou A, Travison TG, Gou RY, Tommet D, Abdeen A, Earp B, Kunze L, Lange J, Vlassakov K, Inouye SK; SAGES II Study Team.

J Am Geriatr Soc. 2023 Jan;71(1):46-61. doi: 10.1111/jgs.18065. Epub 2022 Oct 10.

Retinal Neurodegeneration Measured With Optical Coherence Tomography and Neuroimaging in Alzheimer Disease: A Systematic Review

Carazo-Barrios L, Cabrera-Maestre A, Alba-Linero C, Gutiérrez-Bedmar M, Garzón-Maldonado FJ, Serrano V, de la Cruz-Cosme C, García-Casares N.

J Neuroophthalmol. 2023 Mar 1;43(1):116-125. doi: 10.1097/WNO.0000000000001673. Epub 2022 Oct 18.

Multicultural Healthy Diet to Reduce Cognitive Decline & Alzheimer's Disease Risk: Study protocol for a pilot randomized controlled trial

Mossavar-Rahmani Y, Shaw PA, Hakun JG, Katz MJ, Wylie-Rosett J, Sliwinski MJ.

Contemp Clin Trials. 2023 Jan;124:107006. doi: 10.1016/j.cct.2022.107006. Epub 2022 Nov 14.

Modifiable risk factors of dementia linked to excitation-inhibition imbalance

Hafizi S, Rajji TK.

Ageing Res Rev. 2023 Jan;83:101804. doi: 10.1016/j.arr.2022.101804. Epub 2022 Nov 21.

Cerebrospinal fluid/serum albumin quotient (Q-Alb) is not increased in Alzheimer's disease compared to neurological disease controls: a retrospective study on 276 patients

Giacopuzzi Grigoli E, Solca F, Milone I, Aiello EN, Dubini A, Ratti A, Torresani E, Poletti B, Ticozzi N, Ciusani E, Silani V, Verde F.

Neurol Sci. 2023 Feb;44(2):709-713. doi: 10.1007/s10072-022-06530-w. Epub 2022 Nov 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias